Onward wins FDA approval for ARC-EX system in spinal cord injury patients
The US Food and Drug Administration (FDA) has granted de novo classification to Onward Medical for its ARC-EX system in…
The US Food and Drug Administration (FDA) has granted de novo classification to Onward Medical for its ARC-EX system in…
The US Securities and Exchange Commission (SEC) has opened an investigation into Neuralink, the brain implant company owned by Elon…
Cala Health has finalised the initial closing of an oversubscribed growth round of $50m to support the expansion of patient access…
US-based Silo Pharma has partnered with North Carolina-based Kymanox to jointly design and develop a subcutaneous insertion device for SP-26,…
GE HealthCare has launched Sonic DL for 3D, the latest addition to its imaging portfolio that aims to expedite magnetic…
Neuralink has received approval from Health Canada to launch the first global trial, ‘Canadian Precise Robotically Implanted Brain-Computer Interface’ (CAN-PRIME),…
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) device that…
GE HealthCare has announced the Food and Drug Administration (FDA) 510(k) clearance for its SIGNA MAGNUS magnetic resonance imaging (MRI)…
Fresh off positive data presented at the Clinical Trials on Alzheimer’s Disease 2024 (CTAD) conference earlier this month, Sinaptica’s CEO,…
Nihon Kohden has expanded its portfolio of neurology electrode devices by acquiring a 71.4% stake in NeuroAdvanced Corp., the parent…